West Nile virus infection
A new acute paralytic illness
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To determine the clinical, laboratory, electrodiagnostic, radiologic, and pathologic characteristics that define the spectrum of CNS disease caused by West Nile virus (WNV) infection.
Methods: The records of all patients hospitalized at the Cleveland Clinic from August 2002 to September 2002 with WNV infection were reviewed.
Results: Of 23 cases, the median age was 74 years old, and 74% were men. Symptoms included fever (100%), altered mental status (74%), gastrointestinal complaints (43%), back pain (35%), and rash (26%). In half, meningitis or encephalitis overlapped with flaccid weakness that progressed over 3 to 8 days, with a tendency to be proximal and asymmetric. Laboratory abnormalities included hyponatremia (30%) and initial CSF neutrophilic pleocytosis. Electrodiagnostic studies in two patients showed reduced motor amplitudes with normal conduction velocities and active denervation. In two other patients, reduced sensory amplitudes were also seen. MRI changes included cauda equina enhancement and parenchymal spinal cord signal abnormalities and parenchymal or leptomeningeal signal changes in the brain. Autopsy in three cases showed chronic perivascular inflammation in the brain and inflammatory changes with anterior horn cell loss in the spinal cord.
Conclusion: An overlapping spectrum of meningitis, encephalitis, and myeloradiculitis occurs in CNS WNV infection. Fever, rash, abdominal and back pain, preceding a proximal, asymmetric flaccid weakness, with CSF pleocytosis help distinguish the motor syndrome from Guillain–Barré syndrome. Pathologic changes in the CNS resembled poliomyelitis.
West Nile virus (WNV) was first recognized in the Western Hemisphere in August 1999 when meningoencephalitis, sometimes associated with muscle weakness, was described in 62 patients in New York. Subsequently, 21 patients were reported in 2000 and 66 in 2001.1 In 2002, WNV extended westward, with 3,698 infections reported from 44 states and the District of Columbia and 212 associated deaths.2
We reviewed the neurologic complications of patients hospitalized with WNV, and we report our findings on the clinical, electrodiagnostic, radiologic, and pathologic findings in patients with weakness.
Methods.
We reviewed the medical records of patients hospitalized with CNS WNV infection at The Cleveland Clinic Foundation in August and September 2002. Diagnosis was based on either of the following criteria: 1) IgM positivity in the CSF using the capture ELISA or immunofluorescence assay techniques (Focus Technologies, Cypress, CA); or 2) high simultaneous serum IgG (>0.9 enzyme immunoassay [EIA]) and IgM (>2.0 EIA) titers. Positive results were confirmed by the Ohio Department of Health. Charts were analyzed for demographic variables and clinical characteristics. A symptom was considered present only if specifically recorded. For each patient, the clinical syndrome was defined as meningitis, encephalitis, weakness, or any combination of the above. Weakness was characterized by reviewing the recorded neurologic examinations. Diagnostic laboratory tests, including blood, CSF findings, available neuroimaging, and electrodiagnostic and pathologic studies of brain and spine, were assessed. Peripheral nerves were not examined.
The χ2 contingency test was used to study relations between weakness and the recorded variables.
Results.
Demographics.
Seventeen (74%) of 23 identified cases were men. Median age was 74 years (12 to 85 years). Isolated meningitis, occurring in 22%, was more frequent in younger patients. Isolated encephalitis was present in 22%, isolated weakness in 4%, meningoencephalitis alone in 9%, and all three manifestations in 26%. The remaining 17% had the combination of encephalitis and weakness. All patients lived in Ohio; two had recently traveled, one recalled a mosquito bite, and one acquired the infection from a blood transfusion, confirmed by the American Red Cross and the Centers for Disease Control.
Nine patients required mechanical ventilation: Of those, seven underwent tracheostomy, and six had flaccid quadriparesis.
Three patients (13%) died: two with meningoencephalitis and flaccid quadriplegia and one with isolated encephalitis.
Clinical manifestations and outcome.
Table 1 summarizes the patients’ signs and symptoms. The most frequent presenting symptoms were fever (87%), generalized nonspecific fatigue (65%), and altered mental status (74%). Frequent abdominal complaints and back or limb pain (35%) preceded limb weakness. A nonpruritic, maculopapular, erythematous rash, involving face, arms, or trunk, was present in 26%, beginning 3 to 7 days prior to presentation and completely resolving in all but one case prior to neurologic manifestations.
Table 1 Frequency of different signs and symptoms in our series
Altered mental status was present in 74%, and 48% had headache. Tremor, mainly in the arms, occurred in 26%, usually early in the illness. One patient had palatal myo-clonus, and one had focal facial motor seizures. Facial diplegia, occurring in 17%, was never present at onset.
Weakness developed in 11 (48%) patients and in 8 of them evolved over 3 to 8 days to a flaccid, areflexic paresis that was often proximal and asymmetric, as detailed in table 2.
Table 2 Clinical characteristics of patients with weakness in our series
No presenting symptoms or past medical problems correlated with weakness. Weakness did not correlate with mortality.
Electrodiagnostic testing.
The electrodiagnostic studies of four patients are summarized in tables E-1 and E-2 at www.neurology.org. In general, motor responses are reduced in amplitude with normal latency and conduction velocity, whereas sensory responses may be normal to absent. Needle examination shows active denervation and a neurogenic recruitment pattern, with a tendency toward proximal more than distal distribution.
Laboratory tests.
The diagnosis of WNV was established with a positive CSF IgM in 26% of cases, high serum antibodies in 57%, and both criteria in 17%.
Hyponatremia, observed in 30%, occurred on average 9 days into the illness, once without meningoencephalitis. Investigations in two patients showed a syndrome of inappropriate antidiuretic hormone secretion.
Rhabdomyolysis occurred in two patients with serum creatine kinase levels as high as 20,000 U/L (normal <220 U/L). CSF findings, detailed in table 3, varied relative to onset of symptoms, with pleocytosis ranging from 2 to 1,444 cells/μL (mean 199 cells/μL). Three of four samples submitted for cytology identified the monocyte variants originally described in recurrent aseptic meningitis, namely, Mollaret cells. Protein was usually elevated, ranging between 38 and 317 mg/dL, with values remaining relatively stable with time. In all but one case, CSF glucose was normal.
Table 3 Variation of WBC, PMN, and lymphocyte content of our patients depending on timing of lumbar puncture with respect to onset of symptoms
Radiologic findings.
In 19 patients who had a CT scan of the brain, only 1 was abnormal with an acute posterior cerebral artery territory infarct. Brain MRI (T1, T2, fluid-attenuated inversion recovery [FLAIR], and diffusion-weighted imaging [DWI]), performed on 18 of 23 cases, was abnormal in six. Table E-3 (at www.neurology.org) summarizes the radiologic findings that included abnormalities either involving cortex or brainstem in isolation or cortex plus underlying subcortical white matter (figure 1, A through D). The location (bilateral temporal and subcortical frontoparietal) and enhancement of the white matter abnormalities were atypical for ischemic lesions.
Figure 1. MRI of brain showed T2 signal hyperintensities (A, B) that progressed over the course of 1 week in the brainstem of one patient. They also included subcortical white matter changes best seen on T2 (C) and gyriform areas of restricted diffusion (D). MRI of spine showed gadolinium-enhancing lesions involving the cervical cord (E), conus (F), and cauda equina (G), as shown by the arrows.
Eight of 11 patients with weakness had a spine MRI. Three MRI showed signal changes involving the parenchyma (conus or cervical cord), cauda equina, or both (see figure 1, E through G), usually seen on FLAIR and often enhancing.
Pathology results.
Autopsies were performed on brain in three patients and spinal cord in two. Mild diffuse cerebral edema was seen in one. All brains showed perivascular chronic inflammation involving the meninges and parenchymal vessels with microglial cell proliferation, gliosis, and neuronophagia. Preferential involvement of the brainstem was observed in one. Similar inflammatory and reactive changes were observed in the anterior horn cell (AHC) region in the two spinal cords (figure 2). Focal inflammatory changes also involved the lumbosacral nerve roots (figure 3). Details of one case are published elsewhere.3
Figure 2. Perivascular chronic inflammation and loss of anterior horn cells in the lumbar spinal cord seen in Case 10. Hematoxylin and eosin; original magnification ×200.
Figure 3. Lumbar cord nerve root segment with chronic inflammation seen in Case 10. Hematoxylin and eosin; original magnification ×200.
Discussion.
WNV is predominantly a mosquito-borne disease with peak transmission in late summer and early fall months.1,4⇓ Cases of probable transmission through breastfeeding and organ donation were recently reported.5,6⇓ One of our cases was transfusion related.
Most WNV infections are subclinical, with overt disease occurring in 1 of every 100 to 150 patients.7,8⇓ The early nonspecific symptoms, including fever, gastrointestinal complaints, and back or limb pain, can be seen in many viral infections, including polioviruses. The incidence of rash (26%) in our study is higher than the 19% reported previously.7 Its presence is nonspecific but may point to a viral exanthem and may be compatible with a WNV infection if resolving prior to neurologic manifestations.
The observed hyponatremia is nonspecific and has little diagnostic value late in the infection, but should be looked for as a potential complicating factor.
We noted a stable CSF protein elevation and pleocytosis with initial neutrophil followed by lymphocyte predominance. In polio, the protein concentration also gradually rises to as much as 400 mg/dL and the initial CSF pleocytosis tends to resolve after the first week of paralysis.9 CSF pleocytosis is incompatible with Guillain–Barré syndrome (GBS), a leading differential diagnostic possibility in patients with progressive, diffuse, flaccid weakness. Traditionally, the differential diagnosis of a GBS-like syndrome associated with CSF pleocytosis has included Lyme disease, neoplasia, HIV, and sarcoid meningitis.10 Our data support adding WNV to this list.
Prior reports about WNV infection have emphasized meningoencephalitis with less frequent discussion of the associated weakness.7,8,10,11⇓⇓⇓ The following conclusions can be drawn from reviewing the data in our patients with weakness:
-
Clinically, WNV seems to cause a wide spectrum of motor manifestations ranging from flaccid monoplegia without meningitis or encephalitis to disabling quadriplegia. Rash and abdominal and back pain preceding a proximal asymmetric flaccid weakness with fever may help distinguish the motor syndrome from GBS.
-
Electrodiagnostically, there is no evidence of demyelination, as has been reported by others.1 In one presentation, severe widespread motor axonal loss with normal sensory amplitudes and evidence of reinnervation on subsequent follow-up (Cases 17 and 19) is most consistent with an AHC process. In the two patients with selective motor involvement, the femoral nerve was more affected than the tibial or peroneal nerves, suggesting a more proximal distribution. As illustrated by Case 17, denervation changes may extend to clinically unaffected contralateral muscles. In a second group of patients (Cases 4 and 14), a uniform, more diffuse reduction of motor response amplitudes was found as well as severely reduced sensory amplitudes compatible with involvement of the dorsal root ganglia (DRG) or peripheral axons. Similar findings have previously been interpreted as suggestive of a mixed sensorimotor polyneuropathy.1,7⇓ Our pathologic data, however, favor considering a myelitis affecting not only the AHC but extending to the sensory roots and perhaps DRG as well.
WNV-related weakness has generally been attributed to a GBS-like syndrome with axonal polyneuropathy.1,7⇓ A case reported in 1979 described an “acute anterior myelitis complicating West Nile fever” in a patient with fever, back pain, and left leg flaccid paralysis,12 and more recent case reports also suggested a poliomyelitis–like syndrome from WNV.13,14⇓ It may therefore be useful to compare the WNV and poliomyelitis based on our data. According to Sabin, “paralytic poliomyelitis can now be regarded as a clinical–pathologic syndrome that is caused by enteroviruses, consisting of the three types of polioviruses and probably 19 other enteroviruses.”9
Clinically, both poliovirus and WNV cause a rapidly progressive febrile paralytic illness with an asymmetric and selective proximal pattern. The encephalopathic changes in WNV are, however, incompatible with poliovirus myelitis.9
Pathologically, the typical changes of poliovirus include hyperemia and edema with perivascular lymphocytic infiltration in brain preferentially involving the precentral gyrus, hypothalamus, reticular formation, quadrigeminal bodies, and spinal cord, compressing the AHC and interstitial tissues mostly at the cervical and lumbar cord levels. This is usually followed by chromatolysis in the AHC and cell death. Pathologic changes affecting the sensory roots and DRG were observed in patients with poliovirus infection and were thought to partially explain back and radicular pain seen early in the disease.15,16⇓ We confirmed similar pathologic findings, especially AHC and radicular inflammation, in our autopsies. Unfortunately, neither of the two patients whose cord was examined had electrodiagnostic testing, and only one had a spine MRI showing an enhancing cauda equina (see figure 1F).
In animal studies, intracerebral inoculation with the WNV causes necrosis in the pyramidal cells of the hippocampus and the dentate gyrus, in the AHC, and less frequently in the olfactory bulbs, cerebral cortex, granular cells of the cerebellum, and habenular nucleus.17 Of the prior human autopsies of WNV patients, scattered microglial nodules and perivascular and perineural inflammation, most marked in the medulla, were observed,3,18⇓ again similar to our findings.
Based on current criteria, electrodiagnostic sensory abnormalities are incompatible with the diagnosis of poliomyelitis. Without further investigations, it cannot be determined whether the two different electrodiagnostic patterns described in our WNV cases actually represent independent involvement of motor and sensory axons or whether they reflect only variability in the severity of the myeloradiculopathy.
Although based on a limited number of patients, we note that the only two patients with flaccid paralysis who did not require long-term mechanical ventilation were those with isolated motor involvement.
The facial nerve was the most commonly affected cranial nerve, correlating with rhombencephalitis and abnormal pontine signal on MRI in one patient. Facial palsy was peripheral in type, a pattern frequently seen with GBS, but less commonly encountered with polioviruses (10 to 15% incidence of cranial nerve dysfunction in general) and other nonpolio paralytic viruses.9,19⇓
Clinical and electrodiagnostic abnormalities were confirmed radiologically. T2-weighted and gradient echo signal changes within the cervical cord and the conus were consistent with myelitis, whereas enhancement of the cauda equina suggested polyradiculitis. Prior reports of patients with possible WNV-associated poliomyelitis described normal MRI studies of the spine and brain.13,14⇓ No information on spine imaging is available from the 1999 New York outbreak review. Based on our results, we recommend imaging the spine in patients with WNV encephalitis who also have weakness. The most commonly noted abnormalities on brain MRI in our series included hyperintense T2 and FLAIR signals, sometimes with associated diffusion abnormalities or gadolinium enhancement.
We did not observe an association between weakness and mortality as previously described, probably owing to the smaller number of patients in our series.7
Many clinical, electrodiagnostic, and neuroimaging findings in WNV infections need further elucidation. Clinical and electrodiagnostic follow-up of WNV patients may be useful in recognizing delayed changes similar to the “postpolio” syndrome. Better understanding of the underlying pathophysiologic mechanisms in WNV infection is needed to find targeted therapy and perhaps prevent a new epidemic of an infectious paralysis.
Footnotes
-
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the July 8 issue to find the title link for this article.
- Received December 6, 2002.
- Accepted March 28, 2003.
References
- ↵
- ↵
- ↵
Kelley TW, Prayson RA, Isada CM. Spinal cord disease in West Nile virus infection. N Engl J Med . 2002; 348: 564–565.
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
Asnis DS, Conetta R, Teixeira AA, Waldman G, Sampson BA. The West Nile virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis . 2000; 30: 413–418.
- ↵
- ↵
- ↵
- ↵
- ↵
Sabin AB. Pathogenesis of poliomyelitis: reappraisal in light of the new data. Science . 1956; 123: 1151–1157.
- ↵
Camenga DL, Naythanson N, Cole GA. Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis . 1974; 130: 634–641.
- ↵
- ↵
Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev . 2000; 22: 298–316.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan